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Staphylococcus aureus and Staphylococcus epidermidis are two major skin associated
bacteria, and Substance P (SP) is a major skin neuropeptide. Since bacteria are
known to sense and response to many human hormones, we investigated the effects
of SP on Staphylococci virulence in reconstructed human epidermis model and
HaCaT keratinocytes. We show that SP is stimulating the virulence of S. aureus and
S. epidermidis in a reconstructed human epidermis model. qRT-PCR array analysis of
64 genes expressed by keratinocytes in the response to bacterial infection revealed
a potential link between the action of SP on Staphylococci and skin physiopathology.
qRT-PCR and direct assay of cathelicidin and human β-defensin 2 secretion also provided
that demonstration that the action of SP on bacteria is independent of antimicrobial
peptide expression by keratinocytes. Considering an effect of SP on S. aureus and
S. epidermidis, we observed that SP increases the adhesion potential of both bacteria
on keratinocytes. However, SP modulates the virulence of S. aureus and S. epidermidis
through different mechanisms. The response of S. aureus is associated with an increase
in Staphylococcal Enterotoxin C2 (SEC2) production and a reduction of exolipase
processing whereas in S. epidermidis the effect of SP appears mediated by a rise in
biofilm formation activity. The Thermo unstable ribosomal Elongation factor Ef-Tu was
identified as the SP-interacting protein in S. aureus and S. epidermidis. SP appears as
an inter-kingdom communication factor involved in the regulation of bacterial virulence
and essential for skin microflora homeostasis.
Keywords: skin bacterial communication, substance P, cathelicidin, human β-defensin 2, secretome, biofilm,
thermo unstable ribosomal elongation factor
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INTRODUCTION
Skin is a complex ecosystem including yeasts, fungi, bacteria,
and viruses (Kong and Segre, 2012) and it is estimated that
one billion bacteria colonize each square centimeter of skin
(Grice et al., 2008). Moreover, almost 25% of the microbial
population is located deeply into the skin through hair follicles,
sweat, and sebaceous glands (Lange-Asschenfeldt et al., 2011)
and is in close contact with eukaryotic cells. It has been known
since the end of the twentieth century that bacteria can sense a
large range of eukaryotic communication and defense molecules
(Lesouhaitier et al., 2009). These factors have multiple effects
on bacteria and can regulate their growth, adhesion, invasion,
virulence, and/or biofilm formation activity (Lesouhaitier et al.,
2009). As skin is the largest neuroendocrine organ of the human
body (Roosterman et al., 2006) and many cutaneous hormones,
neurohormones, and defense peptides diffuse in sweat (Cizza
et al., 2008) and upper epidermal layers (Severini et al., 2002),
the skin bacterial microflora is exposed in permanence to these
eukaryotic factors.
The principal skin neuropeptide, Substance P (SP), released
by sensory skin primary afferent C-fibers (Severini et al., 2002)
shows important variations of local concentration under the
effect of pain, stress, and infection (Harrison and Geppetti,
2001; Nakano, 2004; O’Connor et al., 2004). This peptide
of the tachykinin family is involved in the pathogenesis of
numerous skin diseases of multifactorial origins, like atopic
dermatitis (Hosokawa et al., 2009; Misery, 2011). It is currently
suspected that some of the effects of SP are mediated through
interaction with skin microflora (Feuilloley et al., 2015). Indeed,
we demonstrated recently that SP can stimulate the biofilm
formation activity of a cutaneous strain of Pseudomonas
fluorescens (Hillion et al., 2014) and the cytotoxicity of Bacillus
cereus (Mijouin et al., 2013). An effect of SP on two of the
major skin associated bacteria, namely Staphylococcus aureus
and Staphylococcus epidermidis was also suspected (Mijouin
et al., 2013). To date, however, as the effect of SP on
bacteria has only been investigated using cellular models, the
pathophysiological meaning of these observations remained
hypothetical. In addition, the potential mechanism of action of
SP requires clarification. Indeed, the thermo unstable ribosomal
elongation factor (Ef-Tu), a well-known “moonlighting” protein
(Amblee and Jeffery, 2015), was found as a sensor for SP in
B. cereus (Mijouin et al., 2013). However, it has been also
hypothesized that SP could promote the release of antimicrobial
peptides such as the cathelicidin LL37 and human β-Defensin
2 (HBD2) (Brogden, 2005; Hansen et al., 2006). Furthermore,
SP could also act indirectly on the bacterial microflora through
modulation of antimicrobial peptides secretion. Although the
basal concentration of antimicrobial peptides in skin is low and
under the minimal inhibitory bacterial concentration (Lai and
Gallo, 2009), it has been observed that antimicrobial peptides
are detected by bacteria at sub-lethal doses (Hancock and Scott,
2000) where they can induce an unexpected increase of virulence
(Madi et al., 2013).
In the present study, the effect of SP on the virulence of S.
aureus and S. epidermidis was investigated using a reconstructed
human epidermis model and by qRT-PCR array targeting key
proteins involved in the response to bacterial interaction with
the skin. As the expression of some antimicrobial peptides was
not induced, this study was completed by assay of LL37 and
HDB2 secretion by keratinocytes and measurement of the effect
of these antimicrobial peptides on the cytotoxic and biofilm
formation activity of both Staphylococci. Furthermore, the effect
of SP on S. aureus and S. epidermidis adhesion on keratinocytes,
secretome, and biofilm production were determined. These data
lead, to the conclusion that SP exerts a direct control on the
virulence of Staphylococci of physiopathological relevance. The
SP sensory protein in these bacteria was identified.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
S. aureus MFP03 and S. epidermidis MFP04 were isolated
from the skin of healthy volunteers and were characterized
by phenotypic, metabolic, MALDI-Biotyper whole proteome,
and 16S ribosomal RNA gene sequencing techniques (Hillion
et al., 2013). For confocal microscopic studies, bacteria were
transformed using pTeTON-GFP plasmid (Sastalla et al., 2009),
encoding for the green fluorescent protein (GFP) and for
ampicillin resistance. Staphylococci were routinely grown at
37◦C, in Luria-Bertani (LB) broth. For pre-treatment, bacteria
were diluted in fresh LB and the peptides were added at the
beginning of the log growth phase. Bacteria were collected at
mid-log growth phase (i.e., after a mean of 5 h incubation).
Preliminary studies were performed to control for the absence of
effect of the peptides on their growth kinetics. Before application
on reconstructed skin or keratinocytes, bacteria were harvested
by centrifugation and washed with sterile physiological water
to remove any trace of free peptide. The bacterial density
and the absence of contamination were controlled by plating.
Transformed strains were grown in the same conditions except
that ampicillin (100 µg/mL) or kanamycin (100 µg/mL) were
added. The viability of the bacteria in the eukaryotic medium
and under the different culture conditions was determined in
preliminary studies as a control. Substance P (SP), neurokinin A
and the reversed sequence peptide of SP (SPrev) were obtained
from Polypeptides (Strasbourg, France). LL37 and HBD2 were
purchased from Innovagen (Lund, Sweden).
Virulence Assays on Reconstructed
Human Epidermis
The effect of SP and neurokinin A on the virulence of S. aureus
and S. epidermidis was studied using a reconstructed human
epidermis model (RHE, SkinEthic
TM
). The SP N-C reversed
sequence peptide (SPrev) was without effect on the virulence of
both Staphylococci (data not shown) and was used as a control for
the whole study. According to provider instructions, immediately
after reception the culture medium of RHE was changed using
SkinEthic
TM
growth medium and the tissues were allowed to
stabilize for 22 ± 1 h at 37◦C in 5% CO2 atmosphere. The
viability of RHE was measured using the MTT reduction assay
performed according to ESAC-ECVAMandOECDDraft Revised
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Guideline TG431 (ESAC-ECVAM, 2009; OECD, 2014). Briefly,
cellular NAD(P)H-dependent metabolic activity was evaluated
through measurement of the conversion of MTT tetrazolium dye
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
into insoluble purple formazan crystals. For each test, a volume
of 10µL of bacterial culture (107 or 108 CFU/mL) was applied on
each reconstructed epidermis. Sodium dodecyl sulfate [SDS; 5%
(w/v) in water] and phosphate buffer saline (PBS; pH = 7.4, 0.1
M) were used as negative and positive controls, respectively. RHE
were incubated with bacteria for 24 h and then were rinsed three
times with PBS to remove non adherent germs. Tissues were then
incubated in 300µL of MTT solution (1 mg/mL) for 180± 5 min
at 37◦C in 5% CO2 atmosphere. Formazan was recovered from
the tissues by dissolving crystals in 1.5 mL isopropanol at room
temperature for 120 ± 5 min. Tissue viability was determined
by measurement of the optical density (OD) at 540 nm. Results
were expressed as percentages of the negative control values
measured after exposure of RHE to sterile PBS. Negative controls
were validated if the mean OD540 was ≥1.2 and the standard
deviation was ≤18%. Positive controls consisting in SDS 5%
exposure were validated if the mean viability was <40%, and the
standard deviation value was ≤18%. Controls were performed
to verify the absence of interference of bacteria with the MTT
assay.
Gene Expression in Reconstructed Human
Epidermis
The expression of 64 genes encoding for antimicrobial peptides
production, immune immunity proteins, chemokines, cytokines
and their receptors, prostaglandin synthesis, epidermis
differentiation, proteases and metalloproteinases, proteins
involved in phagocytosis, invasion, internatization, cellular
stress, apoptosis, growth factor production, and seboregulation
was analyzed by qRT-PCR array using customized micro-chips
(Bioalternatives, Gencay, France; Table 1). The expression level
of these genes by RHE in the presence of control or SP treated
S. aureus and S. epidermidis was compared to that of cellular
housekeeping genes used as reference. RHE were exposed
to the bacteria as previously described. After rinsing in PBS,
RHE total RNAs were extracted using the Sigma-Aldrich TRI
Reagent R© Protocol. RNA later (Life Technologies cat. AM7020)
was used to protect and stabilize RNA. The Dynabeads R©
mRNA Purification Kit (Life Technologies cat. 61006) was
used to purify total RNA preparations and select mRNA. For
each condition and qRT-PCR array 6 µg of purified mRNA
was used. RNA integrity was checked using an Agilent 2100
Bioanalyzer (Agilent Technologies, Inc.). The yield of the
extracted RHE total RNA was assayed from 1 µl RNA in a
2100 BioAnalyzer using the protocol of the RNA 6000 Nano
Pico kit (Agilent Technologies, Inc.). The RIN values of the
RHE total RNA from triplicates were between 7.9 and 9.3 out
of 10.
Antimicrobial Peptides Assays
The production of antimicrobial peptides, namely cathelicidin
LL37 and Human β-Defensin 2 (HBD2), by keratinocytes in
TABLE 1 | List of the 64 genes encoding proteins investigated by qRT-PCR
microarrays and mRNA expression calculated as percentage of control
genes expression.
S. aureus S. epidermidis
Housekeeping
proteins
(References)
GAPDH Glyceraldehyde-3-
phosphate
dehydrogenase
Control Control
RPS28 Ribosomal protein
S28
Control Control
RPL13A Ribosomal protein
L13a
Control Control
Antimicrobial
peptides and
innate immunity
proteins
CAMP Cathelicidin
antimicrobial
peptide
152.1 41.4
DEFB1 Defensin, beta 1 167.1 52.2
DEFB103A Defensin, beta
103A
ND ND
DEFB4A Defensin, beta 4A 199.5 11.9
PI3 Peptidase inhibitor
3, skin-derived
115.3 74.2
RNASE7 Ribonuclease,
RNase A family, 7
71.8 96.9
S100A7 S100 calcium
binding protein A7
154.7 31.2
HAMP Hepcidin
antimicrobial
peptide
317.2 65.8
TLR1 Toll-like receptor 1 80.7 180.9
TLR2 Toll-like receptor 2 100.1 174.2
TLR3 Toll-like receptor 3 351.7 78.2
TLR4 Toll-like
receptor 4
ND ND
S100A8 S100 calcium
binding protein A8
213.8 55.1
S100A9 S100 calcium
binding protein A9
90.5 107.2
Chemokines IL8 Interleukin 8 239.7 61.8
CCL5 Chemokine (C-C
motif) ligand 5
223.1 101.9
CCL27 Chemokine (C-C
motif) ligand 27
129.4 69.9
CCL20 Chemokine (C-C
motif) ligand 20
167.9 8.9
CXCL1 Chemokine (C-X-C
motif) ligand 1
259.7 35.1
CXCL2 Chemokine (C-X-C
motif) ligand 2
ND ND
CXCL6 Chemokine (C-X-C
motif) ligand 6
ND ND
IL17C Interleukin 17C ND ND
CXCL3 Chemokine (C-X-C
motif) ligand 3
ND ND
CXCL5 Chemokine (C-X-C
motif) ligand 5
ND ND
CXCL10 Chemokine (C-X-C
motif) ligand 10
66.9 348.3
(Continued)
Frontiers in Microbiology | www.frontiersin.org 3 April 2016 | Volume 7 | Article 506
N’Diaye et al. Effect of Substance P on Staphylococci
TABLE 1 | Continued
S.aureus S.epidermidis
Cytokines and
cytokines
receptors
IL4R Interleukin 4
receptor
88.4 123.9
IL13RA2 Interleukin 13
receptor, alpha 2
174.2 ND
IL23A Interleukin 23,
alpha subunit p19
ND ND
IL6 Interleukin 6 ND ND
TSLP Thymic stromal
lymphopoietin
107.4 109.7
IL1A Interleukin 1, alpha 1088.6 62.1
IL1B Interleukin 1, beta 147.1 38.4
IL24 Interleukin 24 ND ND
TNF Tumor necrosis
factor
82.2 215.1
Prostaglandin
synthesis
enzyme
PTGS2 Prostaglandin-
endoperoxide
synthase 2
79.6 118
Markers of
differenciation
and proliferation
FLG Filaggrin 156.5 61.1
LOR Loricrin 150.6 77.7
CDSN Corneodesmosin 94.2 87.5
KRT5 Keratin 5, type II 32 393
KRT10 Keratin 10 128.9 56
KRT19 Keratin 19, type I 115.3 95.9
MKI67 Marker of
proliferation Ki-67
106.2 174.5
Proteases and
Metalloproteinases
ADAM17 ADAM
metallopeptidase
domain 17
54.7 119.2
KLK5 Kallikrein-related
peptidase 5
39.9 243.5
KLK7 Kallikrein-related
peptidase 7
141.4 65.5
MMP1 Matrix
metallopeptidase 1
215.6 211.4
MMP3 Matrix
metallopeptidase 3
322.8 51
MMP9 Matrix
metallopeptidase 9
68.6 530.2
Proteins involved
in phagocytosis,
invasion, and
internalization
RAC1 Ras-related C3
botulinum toxin
substrate 1
162 71.9
ILK Integrin-linked
kinase
148 58.5
ITGA5 Integrin alpha 5 245.1 420.5
ITGB1 Integrin beta 1 114.9 102.03
DPP4 Dipeptidyl-
peptidase 4
121.6 228.7
STIP1 Stress-induced
phosphoprotein 1
57.6 154.4
Markers of
cellular stress
and apoptosis
ATF3 Activating
transcription
factor 3
53.6 207.7
(Continued)
TABLE 1 | Continued
S.aureus S.epidermidis
HMOX1 Heme oxygenase
(decycling) 1
54.3 124.1
TP53 Tumor protein p53 37.9 196.8
TP63 Tumor protein p63 295.3 193.6
Growth factors
and receptors,
proteins of
seboregulation
IGF1R Insulin-like growth
factor 1 receptor
65.1 148.9
SRD5A1 Steroid 5α
reductase, α
polypeptide 1
89.5 77
CSF2 Colony stimulating
factor 2
210.5 56.4
ND, Non Detectable.
response to exposure to SP (10−6 M) or SPrev (used at the
same concentration as a control) and bacteria pre-treated with
SP or SPrev (10−6 M) was studied using the HaCaT keratinocytes
cell line (CLS, Eppelheim, Germany). HaCaT cells were grown
at 37◦C in 5% CO2 atmosphere in Dulbecco’s modified Eagle’s
medium (DMEM, Lonza) containing 25 mM glucose and
supplemented with 10% inactivated fetal bovine serum, 2 mM
L-glutamine (Lonza) and antibiotics (penicillin 100 IU/mL and
streptomycin 100 µg/mL). Cells were used between passages 41
and 65. They were seeded in 24 well plates at a final density
of 5∗105 cells per well, and grown for 48 h before use. A
minimum of 24 h before interaction with bacteria, cells were
starved of antibiotics and fresh serum-free medium was added.
Antimicrobial peptides were assayed using human cathelicidin
(cat. CSB-EL004476HU) and β-Defensin 2 (cat. CSB-E13201h)
Elisa kits according to the manufacturer’s protocol (Cusabio,
Wuhan Hi-tech Medical Devices Park, China).
Cytotoxicity, Adhesion, and Invasion
Assays
The cytotoxic potential of the bacteria was determined by
measurement of lactate dehydrogenase (LDH) release by HaCaT
cells due to cytoplasmic membrane destabilization. HaCaT cells
were infected with mid-log growth phase bacterial suspension
at a bacterium-to-cell ratio of 10:1. As previously indicated,
bacteria were carefully rinsed before use to remove any trace
of free peptide. The amount of LDH released by HaCaT cells
was determined after 15 h of incubation using the Cytotox 96
enzymatic assay (Promega, France; Picot et al., 2003). Control
studies performed using bacteria alone showed that none of
the strains used in the present study produced metabolites
interfering with the assays. For adhesion assays, after incubation
with bacteria cells were gently washed with DMEM and then
disrupted with 0.9% (v/v) Triton X100 in physiological water.
Viable bacteria (intra- and extra-cellular) were counted by plating
on Tryptic Soy Agar (TSA). Invasion was quantified by the
gentamicin protection assay as previously described (Mezghani-
Abdelmoula et al., 2004).
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Secretome Analysis
Supernatants of S. aureus and S. epidermidis exposed to SP or
SPrev were obtained by centrifugation and filtration. Proteins
were precipitated by addition of trichloroacetic acid on ice.
These proteins were harvested by centrifugation, washed in
cold acetone, dried at room temperature, and resuspended
in rehydratation buffer as described (Barbey et al., 2012).
The protein concentration was determined by Bradford assay.
Proteins were separated on 12% w/v polyacrylamide gel. For
2D-gel electrophoresis, protein samples were first separated by
isoelectric focusing (IEF) using pH 4 to 7 non-linear IEF strips
(GE Healthcare). The strips were then transferred horizontally
onto 12% polyacrylamide gels, covered with 0.5% agarose
and the second dimension separation was run. Proteins were
visualized by colloidal Coomassie Brilliant Blue G250 staining.
Gel images were captured using a GS-800 densitometer (Bio-
Rad Laboratories). Variations of spot intensity and distribution
were studied using the Bio-rad PDQuest 2D R© analysis software.
Electrophoretic bands and spots of interest were dissected and
submitted to in-gel trypsin digestion (Barbey et al., 2012)
and analyzed by Matrix Assisted Laser Desorption Ionization
Time-of-Flight mass spectrometry (MALDI-TOF/TOF) using
an AutoFlex III mass spectrometer (Bruker Daltonics). The
spectrometer was used in a positive/reflector mode. Samples
were spotted to MTP 384 ground steel targets (Bruker
Daltonics) using freshly prepared matrix solution composed
of 2,5-dihydroxybenzoic acid (20 mg/mL) in a solution of
trifluoroacetic acid and acetonitrile [0.1 and 50% (v/v) in water].
Each spectrum was established over an average of 500–1000
laser shots. The FlexAnalysis software generated an MS peak list
which was submitted for peptide mass fingerprinting using the
integrated software Biotools (Version 3.2). The NCBI data base
was searched using the online MASCOT software and statistical
sequences analyses were performed using the probability-based
Mowse score.
Biofilm Formation Studies
The effect the antimicrobial peptides and SP on the biofilm
formation activity of S. aureus MFP03 and S. epidermidis
MFP04 was investigated by the crystal violet technique and
by confocal laser scanning microscopy using GFP-transformed
strains. The crystal violet technique was adapted from O’Toole
et al. (2000). An aliquot of bacterial culture adjusted to
OD580 = 0.4 was layered in a polystyrene microtitration plate
in presence or not of peptides. After 24 h of incubation at
37◦C the bacterial suspension was removed and the wells were
rinsed and the remaining bacteria were stained with crystal
violet (0.1%) for 30 min. After rinsing again with distilled
water, the dye was recovered and the OD595 was measured.
For microscopic studies, bacteria were inoculated at OD580
= 0.08 into fresh LB medium and grown in the presence of
the peptides. Bacteria were then washed and resuspended in
sterile physiological water. The suspension was adjusted to an
OD580 = 1 and poured in Petri dishes containing sterile glass
slides. Glass slides were removed after 2 or 24 h incubation,
washed, heat fixed, and immediately observed using a LSM 710
inverted confocal laser-scanning microscope (Zeiss, Germany).
Three-dimensional (3D) images and orthocuts were obtained
using Zen R© 2009 software. Biofilm thickness was quantified with
the same software.
Identification of the Substance P Binding
Protein
Mid-log growth phase SP treated bacterial cultures were
centrifuged at 7000 × g for 10 min at room temperature. The
pellets were resuspended in 5 mL of lysostaphine (10 µg/mL).
This mix was incubated for 1 h at 37◦C with shaking at 180 rpm.
Then, bacteria were centrifuged for 20 min at 7000 × g at 4◦C.
Each pellet was solubilised in 6 mL of non-denaturing lysis buffer
(Tris-HCl 50 mM pH 8, EDTA 4 mM, NaCl 137 mM, glycerol
10% (v/v), Triton X-100 1% (v/v), Phenylmethylsulfonyl-fluoride
1 mM) and supplemented with a protease inhibitors cocktail
(Boehringer, Reims, France). Four cycles of freezing/thawing
were applied to the suspension (−80◦C for 20 min/37◦C for
10 min). Bacterial lysis was completed by sonication using
short pulses (1 min) on ice. The cell lysate was centrifuged at
13,000 × g at 4◦C for 10 min to remove unbroken cells and
the supernatant was ultra-centrifuged at 35,000 rpm for 50 min
to isolate the membrane fraction. Membrane proteins were then
solubilized in Tris-HCl 50 mM pH 8, MgCl2 10 mM, Triton X-
100 2%, Phenylmethylsulfonylfluoride 1 mM supplemented with
a protease inhibitors cocktail.
The SP binding sites was identified by immunoprecipitation
using a technique adapted from Mijouin et al. (2013). Sixty
microliters of G protein-coupled agarose beads (Millipore) and
1.5 µg SP monoclonal antibodies (Abcam, Paris, France) were
incubated overnight at 4◦C. Meanwhile, 1.5mg of bacterial
membrane protein extract was incubated with SP or SPrev (10−6
M) for 1 h at room temperature under slow orbital agitation.
To reduce the non-specific binding, 50 µL of rabbit polyclonal
serum was added. Unlabelled G protein-coupled agarose beads
were added to remove non-specific complexes. The samples
were incubated for 30 min at 4◦C under slow orbital agitation.
Unlabelled beads were removed by centrifugation (10,000 ×
g, 4◦C, 10 min). The supernatant containing the SP bound
ligand was then mixed to the SP antibody-associated beads
and incubated for 1 h at room temperature under slow orbital
agitation. Beads were collected, washed two times with 250 µL of
non-denaturing lysis buffer. Then, 50 µL of Laemmli 2x buffer
[Tris-HCl 200 mM pH 6.8, glycerol 45% (v/v), SDS 6% (v/v), β-
mercaptoethanol 6% (v/v), and bromophenol blue 0.03% (w/v)]
was added and boiled for 5 min to separate the ligand from the
beads. To visualize SP-bound proteins, beads were removed by
centrifugation (14,000 × g, 4◦C, 5 min) and the supernatant was
run on a 12% w/v polyacrylamide gel SDS-PAGE. Proteins were
visualized by colloidal Coomassie Blue G250 staining (Sigma).
As Ef-Tu was previously identified as the SP-binding site in
B. cereus (Mijouin et al., 2013), we studied the identity of the
SP binding protein in S. aureus and S. epidermidis by Western-
Blot using polyclonal anti-Ef-Tu antibodies. These antibodies
were produced in rabbit by Biogalenys SAS (Miserey, France)
by immunization against the full 397 amino acids sequence
of Pseudomonas aeruginosa Ef-Tu (UniProtKB/Swiss-Prot:
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P09591). Ef-Tu was obtained recombinantly from Escherichia
coli using a synthetic codon optimized gene for P. aeruginosa
Ef-Tu (MWG Operon) containing the leader sequence
MHHHHHHSSGVDLGTENLYFQ∗S to provide a cleavable
6∗His tag. This was cloned into the NcoI and HindIII restriction
sites of the pET-Duet1 vector (Novagen) and transformed
into E. coli Rosetta2 (DE3) (Novagen). Proteins from mid-log
growth phase bacteria were purified at 4◦C using a 1 mL
HisTrap crude FF column and a Superdex 200 16/600 h column
(GE Healthcare) associated to an ÄKTAxpress system (GE
Healthcare). For Western-Blot, immunoprecipitation SDS-
PAGE gels were transferred onto nitrocellulose membranes
at 50 mA for 1 h in TRIS base (192 mM) transfer buffer
containing glycine (14.5% g/L w/v) and methanol (20% v/v)
using a BioRad Mini TransBlot Electrophoretic Transfer Cell
system. Membranes were then air-dried and immersed for 2 h in
blocking buffer [Tris buffer saline (TBS): 50 mM, 150 mM NaCl,
5% whole milk]. Membranes were incubated with the primary
antibody raised against Ef-Tu (1:100 in blocking buffer) at room
temperature for 2 h while shaking. After incubation, the blot was
washed three times in 1x TBS supplemented with 0.05% (w/v)
Tween 20 for 30 min and incubated for 1.5 h while shaking with
secondary antibody diluted 1/5000 (goat anti-rabbit IgG alkaline
phosphatase conjugate, Biorad). Electrophorectic bands were
detected using an alkaline phosphotase conjugate substrate kit
(Biorad). P. aeruginosa Ef-Tu was used as positive control, and
QSDA, a N-acyl homoserine lactonase, was used as a negative
control.
Statistical Analysis
All experiments were conducted independently at least three
times at different days. The results are expressed as mean
± SEM and statistical differences were determined using the
Student’s t-test. Significant differences were noted as ⋆, ⋆⋆, and
⋆⋆⋆ for p-values < 0.05, < 0.01, and < 0.001, respectively. For
each biofilm, the thickness was calculated from a minimum of
20 measures in different fields using the Zen R© 2009 software
(Zeiss). The mean biofilm thickness was quantified over three
different experiments and the Student t-test was used to
compare the means. SDS-PAGE electrophoresis, bidimensional
electrophoresis, immunoprecipitation, and Western Blot figures
are representative of three independent experiments.
RESULTS
Substance P Increases the Virulence of
S. aureus and S. epidermidis on
Reconstructed Human Epidermis
Preliminary controls showed that exposure of S. aureus MFP03
and S. epidermidis MFP04 to SP (10−6 M) did not modify their
growth kinetics (data not shown). The SP reversed sequence
peptide (SPrev) was without effect on the virulence of S. aureus
(Figure 1A) and S. epidermidis (Figure 1B) on RHE. This peptide
(with the same amino acids composition as SP) was used as a
control for the rest of the study allowing excluding any metabolic
effect. When RHE were incubated in the presence of S. aureus
FIGURE 1 | Viability of reconstructed human epidermidis (RHE)
exposed to S. aureus MFP03 (A) or S. epidermidis MFP04 (B) (107 or
108 CFU/mL) pre-treated with Substance P reverse (SPrev) used as a
control or Substance P (SP) (10−6 M) (⋆⋆⋆p < 0.001).
(107 or 108 CFU/mL) pre-treated with SP (10−6 M) the MTT
assay for cell metabolic activity revealed a significant decrease
in the viability of the RHE (−19.36 ± 0.01% and −23.23 ±
0.01%, p < 0.001, respectively; Figure 1A). The effect of SP on
S. epidermidis was similar with a reduction of RHE viability of
11.63 ± 0.01 and 19.70 ± 0.01% after incubation with bacterial
culture (107 or 108 CFU/mL, p< 0.001, respectively; Figure 1B).
Neurokinin A, another peptide of the tachykinin family also
expressed in significant amount in skin (Roosterman et al.,
2006), was totally without effect on S. aureus and S. epidermidis
virulence (data not shown) when used at the same concentration
as SP (10−6 M).
Substance P Treated Bacteria Affect the
Expression of Proteins Involved in Host
Defense and Inflammation in
Reconstructed Human Epidermis
RHE were exposed to control (SPrev) or SP treated bacteria, and
expression changes of 64 genes was determined by qRT-PCR
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microarray (Table 1). Genes showing significant variations (>
+200% for up-regulation and < −50% for down-regulation) are
shown in Figure 2. SP-treated S. aureus led to alter expression
of 12 RHE mRNAs, among which nine were over-produced
[TLR3, one antimicrobial peptide (the hepcidin antimicrobial
peptide), three chemokines (Interleukin 8, Chemokine ligands 1
and 5), two matrix metalloproteases (1 and 3), one cell contact
protein (Integrin α5), and one growth factor (Colony stimulating
factor 2), while three were under-produced (type II keratin
5, kallikrein-related peptide 1, and tumor protein 53)]. The
maximal differences were obtained for TLR3 mRNA expression
that reached+251± 17%, p< 0.001 (Figure 2A). In the case of S.
epidermidis, expression of 10 genes was affected in RHE exposed
to SP-treated bacteria (Figure 2B). Noticeably, only the two
mRNAs encoding metalloprotease 1 (+111± 35%, p< 0.05) and
integrin α5 (+320 ± 39%, p < 0.001), were increased similarly
as in S. aureus. Four other mRNAs were also significantly
over expressed, namely those encoding for chemokine ligand
10 (+248 ± 67%, p < 0.01), tumor necrosis factor (+115 ±
23%, p < 0.01), dipeptidyl-peptidase 4 (+129 ± 23%, p <
0.001), and activating transcription factor 3 (+108 ± 29%, p <
0.05). Conversely, the expression of defensin β4, S100 calcium
binding protein A7, chemokine ligand 20, and interleukin 1β was
reduced.
Substance P Stimulates the Secretion of
Cathelicidin by Keratinocytes But Control
and SP Treated Bacteria Have Limited
Effects on Antimicrobial Peptides
The effect of SP and of SP-treated S. aureus and S. epidermidis
on cathelicidin LL37 and β-defensin 2 (HBD2) productions by
HaCaT keratinocytes was studied. By itself SP (10−6 M) alone
induced a marked increase in LL37 secretion (+212 ± 2%, p <
0.001; Figure 3A). Conversely a decrease in HBD2 was observed
(−32 ± 1%, p < 0.01). Unexpectedly, exposure of HaCaT
cells to SPrev alone lead to similar results with a rise of LL37
(+237 ± 20%, p < 0.01) and a reduction of HBD2 production
(−19 ± 6%, p < 0.05). When keratinocytes were exposed to S.
aureus pre-treated with SP (10−6 M) a decrease in LL37 and
HBD2 secretion (−15.8 ± 0.7%, p < 0.05 and −54 ± 2%, p <
0.01, respectively) was noted (Figure 3B). Similar results were
observed when HaCaT cells were exposed to SP pre-treated S.
epidermidis, with a reduction of antimicrobial peptides secretion
that reached−42.8± 0.8% (p< 0.001) for LL37 and−29± 2% (p
< 0.01) for HBD2 (Figure 3C). However, when HaCaT cells were
exposed to control SPrev-treated S. aureus, there was an increase
in LL37 secretion. In all other controls, there was a reduction in
antimicrobial peptides secretion, as was observed with SP-treated
micro-organisms.
Cathelicidin and β-Defensin 2 Have No
Effect on the Cytotoxicity on S. aureus and
Decrease that of S. epidermidis
Preliminary studies showed that LL37 and HBD2 at a
concentration of 1 µg/mL alone or in association were without
effect on the growth of S. aureus and S. epidermidis (data not
FIGURE 2 | Relative expression of genes encoding for response to
infection and inflammation proteins by reconstructed human
epidermidis (RHE) exposed to S. aureus MFP03 (A) or S. epidermidis
MFP04 (B) pre-treated with Substance P. Results are expressed as
percentages to control RHE exposed to bacteria pre-treated with Substance P
reverse (dotted line = 100%). Each value represents the mean ± SEM of three
independent experiments. Only genes showing significant variation of
expression on the 64 (⋆p < 0.05; ⋆⋆p < 0.01; ⋆⋆⋆p < 0.001). Names of
proteins are given in Table 1.
shown). Both antimicrobial peptides were totally without effect
of the cytotoxic activity of S. aureus on HaCaT cells (Figure 4A).
In the absence or presence of LL37 and/or HBD2 only non-
significant variations of biofilm formation were observed with
S. aureus. Conversely, treatment of S. epidermidis with LL37 (1
µg/mL) resulted in a marked reduction of cytotoxicity (−77 ±
4%, p < 0.01; Figure 4B). Exposure of S. epidermidis to HBD2
showed a more marginal, but significant, decrease in bacteria
cytotoxicity on HaCaT cells (−17 ± 1%, p < 0.05). However,
when the two peptides were used in association, their individual
effects on S. epidermidis cytotoxicity were totally abolished.
Similarly to S. aureus, neither LL37 nor HBD2 treatments
were leading to significant altered biofilm formation. However,
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FIGURE 3 | Effect of Substance P (SP) and Substance P reverse (SPrev) (A), Substance P reverse (SA-SPrev) and Substance P treated S. aureus
(SA-SP) (B) and Substance P reverse (SE-SPrev) and Substance P treated S. epidermidis (SE-SP) (C) on cathelicidin LL37 and β-defensin 2 production
by HaCaT keratinocytes. On each figures, dotted lines indicate the basal production of LL37 and HBD2 by HaCaT in the absence of treatment (control). Each value
is the mean ± SEM of three independent experiments. (NS = non significant; ⋆p < 0.05; ⋆⋆p < 0.01; ⋆⋆⋆p < 0.001).
association of both peptides led to slightly reduce biofilm
production of S. epidemidis.
Substance P Increases Adhesion of
S. aureus and S. epidermidis on
Keratinocytes
The gentamicin protection assay was used to obtain a
measurement of total cell-associated bacteria. This revealed that
SP strongly increased the adhesion potential of S. aureus and
S. epidermidis on HaCat keratinocytes (+438 ± 24%, p < 0.001
and +307 ± 13%, p < 0.001, respectively; Figure 5). Conversely,
the invasion potential of both Staphylococci remained unchanged
(data not shown). Used at the same concentration (10−6M), SPrev
had no effect on the adhesion potential of the two bacteria.
Substance P Promotes the Release of
Enterotoxin C2 and Blocks Exolipase
Processing in S. aureus
The secretome from mid-log growth phase cultures of S. aureus
and S. epidermidis corresponding to the conditions of the
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FIGURE 4 | Effect of the cathelicidin LL37 (1 µg/mL) and of β-defensin 2 (HBD2) (1 µg/mL) alone or in association on the cytotoxicity and biofilm
formation activities of S. aureus MFP03 (A) and S. epidermidis MFP04 (B). Dotted lines indicate the basal cytotoxicity and biofilm formation activity of bacteria
in the absence of treatment (control). Each value is the mean ± SEM of three independent experiments. (⋆p < 0.05; ⋆⋆p < 0.01).
FIGURE 5 | Effect of Substance P (SP) and Substance P reverse (SPrev)
(10−6 M) on the adhesion properties of S. aureus MFP03 and
S. epidermidis MFP04 on HaCaT keratinocytes. The dotted line indicates
the basal adhesion of bacteria (100%) in the absence of treatment (control).
Each value is the mean ± SEM of three independent experiments (⋆⋆⋆p <
0.001).
adhesion assays were studied by 2D-gel electrophoresis. Image
analysis of three replicates of 2-D gels allowed the detection
of intensity variations in six major spots between control and
SP treated S. aureus (Figure 6A). Two of these spots (1 and 6)
were down regulated proteins, whereas the four others are over
produced in response to SP (Figure 6B). Spots 1 and 4 were
identified byMALDI-TOF/TOF analysis as the staphylococcal 77
kDa lipase and the 44 kDa lipase precursor, respectively. Spot 2
was identified as the 32 kDa staphylococcal enterotoxin C2. As
presented in Table 2, the three other spots were proteins involved
in folding and potential intermediate metabolism enzymes.
The secretome of S. epidermidis showed a limited number of
exoproteins and no difference was observed between control and
SP-treated bacteria.
Substance P Increases the Biofilm
Formation Activity of S. epidermidis
The biofilm formation activity of Staphylococci was investigated
in static conditions on glass slides by confocal laser scanning
microscopy. Biofilm production by S. aureus MFP03 was very
limited and remained unchanged in the presence of SP. In
contrast, after a 2 h treatment with SP (10−6 M), themean surface
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FIGURE 6 | Bidimensional electrophoresis analysis of secreted S. aureus MFP03 proteins after 1 h treatment with Substance P reverse (Control) or
Substance P (SP) (10−6 M). (A) Six spots were modified after exposure of the bacteria to SP. (B) Two proteins (1 and 6) were markedly decreased whereas the
expression of four others was upregulated. Proteins corresponding to these spots are presented in Table 2. Results are representative of three independent
experiments.
TABLE 2 | Proteins under- and over-expressed in the secretome of Substance P treated S. aureus MFP03 identified by MALDI-TOF/TOF.
Spot NCBl accession Gene Putative Protein Mascot Nb of matched Coverage (%) Mass(Da)
number number name function domain(s) score peptides & pI
1 EEV69102 Lipase Predicted acetyltransferase
and hydrolase with α/β
hydrolase fold domain
274 39 52 76557/8.38
2 EFK82013 sec4 Staphylococcal
enterotoxin C2
Staphylococcal/Streptococcal
toxin 0B-fold and grasp
domain
156 18 56 32654/7.6
3 YP_0057 44993 tig Prolyl isomerase
Protein export
(chaperone)
126 12 29 48893/5.35
4 A8W37176 Lipase precursor Esterase lipase domain 135 14 37 44329/6.83
5 NP372219 citZ Citrate synthase Coenzyme A binding site,
oxalacetate citrate binding site,
catalytic triad
205 18 39 42566/6.41
6 YP_500307 Hypothetical
protein
SAOUHSC_01802
Oxalacetate citrate binding
site, coenzyme A binding site,
catalytic triad
116 13 33 3237117.17
coverage of SP-treated S. epidermidis MFP04 was markedly
increased (Figure 7A). Both density and thickness of the biofilm
were higher. As calculated using the Zen R© software, after a 2
h exposition to SP the mean thickness of the biofilm evolved
from 5 to 9 µm (Figure 7B). This effect was maintained after 24
h exposition to SP with a mean biofilm thickness of 6 µm for
control and 12 µm for SP treated bacteria (Figure 7B).
The Ribosomal Elongation Factor Ef-Tu
Acts as a Substance P Binding Protein in
Staphylococci
The presence of a SP binding site was investigated in the
membrane of S. aureus and S. epidermidis. The properties of
SP (ionic charge and structure) limit its potential penetration in
bacteria. Furthermore, a membrane form of Ef-Tu has previously
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FIGURE 7 | Effect of Substance P reverse SPrev (Control) and Substance P (SP) (10−6 M) on the biofilm formation activity of S. epidermidisMFP04. The
biofilm formation activity of bacteria was observed after 2, 5, and 24 h. (A) Two dimensions (2D), reconstructed three-dimensions (3D) and ortho cuts (3D/z) images.
Pictures are representative of three independent experiments. (B) Evolution of the thickness of the biofilm after 2 and 24 h incubation with SP. Each value represents
the mean ± SEM of three independent experiments (⋆⋆p < 0.01; ⋆⋆⋆p < 0.001).
been identified as the SP receptor in B. cereus (Mijouin et al.,
2013). A band, corresponding to a 43 kDa protein, was found
by immunoprecipitation as a ligand of SP in S. aureus and
S. epidermidis membrane extracts (Figure 8A). Binding of SPrev
on the same 43 kDa protein, was also observed in S. aureus
and S. epidermidismembrane extracts but with a lower intensity.
Nevertheless, SPrev is an inverted peptide (i.e., the sequence is
not scrambled), and some epitopes of native SPmay be preserved.
Identification of the 43 kDa SP binding molecule as the Ef-Tu
protein was demonstrated by western blot using an antibody
raised against P. aeruginosa Ef-Tu (73% sequence identity to Ef-
Tu from S. aureus and S. epidermidis; Figure 8B). The identity of
Ef-Tu as the SP binding protein was confirmed by MALDI-TOF
analysis of SDS-PAGE SDS bands with MASCOT scores>98 and
a coverage percentages>60%.
DISCUSSION
In the present work, we show that SP, at a concentration in the
same range as potentially present in sweat or in intradermal areas
(Ostlere et al., 1995; Cizza et al., 2008) promotes the virulence of
Staphylococci on reconstructed human epidermidis (RHE). RHE
is a simplified skin model in which keratinocytes are grown on an
artificial matrix but, as with human epidermidis, they show a fully
differentiated stratum corneum (Pendaries et al., 2015). They are
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FIGURE 8 | SDS-PAGE analysis of S. aureus and S. epidermidis
Substance P (SP) binding proteins separated by immunoprecipitation
and labeled by colloidal Coomassie Blue G250 staining (A) and
identified by western blot after transfer on nitrocellulose gel using P.
aeruginosa Ef-Tu polyclonal antibidodies (B). Line 1, ladder; Line 2, P.
aeruginosa Ef-Tu (mass marker and positive control for western blot); Line 3,
QSDA protein (negative control for western blot); Line 4, Substance P treated
S. aureus membrane extracts (SA SP); Line 5, Substance P reverse treated S.
aureus membrane extracts (SA SPrev); Line 6, Substance P treated S.
epidermidis membrane extracts (SE SP), Line 7: Substance P reverse treated
S. epidermidis membrane extracts (SE SPrev). Results are representative of
three independent experiments.
therefore, close to the behavior of human skin explants, without
the drawback of their variability and the presence of remaining
commensal germs that are almost impossible to eliminate. qRT-
PCR arrays reveal that SP-treated S. aureus and S. epidermidis
induced a significant and specific response of RHE. Treatment
of S. aureus by SP was leading to up-regulation of the expression
of at least nine mRNA, among which the one showing the main
increase was encoding TLR3, a protein involved in pathogen-
associated molecular patterns (PAMPs) recognition (Lebre et al.,
2007). The associated over-expression of chemokines (CCL5
and CXCL1) is consistent with an increase in the virulence
of SP treated S. aureus and the up-regulation of interleukin
8 (IL8) suggests that an inflammatory response in RHE has
been activated, as is observed in skin (Nedoszytko et al., 2014).
Hepcidin antimicrobial peptide (HAMP) modulates iron storage
and its increase also suggests inflammation pathways are being
activated (Andrews, 2004). HAMP has a broad antimicrobial
spectrum but S. aureus is considered almost insensitive to this
peptide (Lombardi et al., 2015) suggesting that the effect of SP on
S. aureus is independent of HAMP. Nevertheless, it is interesting
to note that SP-treated S. aureus did not induce the expression
of any other studied antimicrobial peptide. The response of
RHE to SP-treated S. epidermidis is notably different. Integrin
α5, the principal protein whose expression was increased, is
involved in S. aureus (Alva-Murillo et al., 2014) and Streptococci
(McFadden et al., 2009) internalization leading to cutaneous
lesions associated to psoriasis (McFadden et al., 2009). It has
been also recently demonstrated that over-expression of the
chemokine ligand 10 (CXCL10), as was observed here with of SP-
treated S. epidermidis, is clearly associated with psoriasis (Ferrari
et al., 2015). It is too soon to postulate a link between the effect
of SP on S. epidermidis and S. aureus and psoriasis, but this
hypothesis is worthy consideration.
It was postulated that SP could act indirectly on bacteria
through activation of LL37 and HBD2 secretion (Brogden, 2005;
Hansen et al., 2006). However, these antimicrobial peptides
are either secreted by cleavage from a precursor or require
induction delay making qRT-PCR poorly adapted to their study.
Their expression was therefore followed by immunoassay. We
observed that SP indeed stimulates LL37 production, but SPrev
has a similar effect, suggesting that this response is poorly
specific and that structural homologies between these peptides
are sufficient to activate the keratinocytes response. Conversely
SP and SPrev provoked a marginal but significant reduction
of HBD2 secretion. A potential effect of SP-treated bacteria
on LL37 and HDB2 secretion was then investigated. Although
significant differences of response amplitude were noted, control
and SP-treated bacteria had globally the same effects. Moreover,
all Staphylococci exposed to SP showed a significant decrease
of LL37 or HDB2 secretion. The study of a potential effect of
SP on bacteria through antimicrobial peptides secretion was
completed by determination of the effect of LL37 and HBD2 on
the cytotoxicity and biofilm formation activity of S. aureus and S.
epidermidis. Alone or in association, these antimicrobial peptides
were without significant effect on S. aureus activity. In the case
of S. epidermidis a decrease of cytotoxicity and biofilm formation
was observed. Taken together, the present data demonstrate that
the effect of SP on the virulence of Staphyloccoci is not mediated
through activation of antimicrobial peptide secretion.
To get further insights into the role of SP in promoting
Staphyloccoci virulence, we next investigated the effects of SP
on the adhesion and invasion potential of bacteria. Exposure
of both Staphylococci to SP resulted in a marked increase
of their adhesion potential on keratinocytes whereas their
invasive activities were unchanged. Adhesion is a key step in
internalization and we cannot exclude that invasion occurs later
or an effect of SP-treated Staphylococci on the internalization
of other bacterial species such as was observed by exposure of
cells to Eap, the multifunctional extracellular adherence protein
of S. aureus (Bur et al., 2013). Further studies, by analysis of
the secretome and biofilm formation activity of S. aureus and
S. epidermidis, revealed that the two bacteria have very different
reactions to SP, albeit they all act in the same sense of an
increase of their infectious potential. Indeed, whereas SP had
no effect on the release of exoproteins by S. epidermidis, SP
stimulated the production of the Staphylococcal enterotoxin C2
by S. aureus MFP03. It is particularly interesting to note that
Staphylococcal enterotoxins are members of a family of bacterial
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toxins that are increased in S. aureus strains associated with
atopic dermatitis (Nada et al., 2012), psoriasis (Atefi et al., 2014),
and even diabetic foot ulcers (Vu et al., 2014). In parallel, in
S. aureus SP induced a decrease in the production of a lipase,
whereas the lipase precursor accumulated suggesting that under
the influence of SP, the precursor was not processed. We cannot
exclude that this reaction had also an indirect effect on the
virulence of S. aureus. Indeed, if the lipase activity is reduced,
this can favor an accumulation of lipids on the skin surface.
A hydrophobic environment is particularly important for the
growth of this bacterium (Wright et al., 2004). In addition, S.
aureus is sensitive to long chain unsaturated free fatty acids,
which act as a barrier to its colonization and infection and exert
a direct antimicrobial activity (Kenny et al., 2009). In the case
of S. epidermidis, whose secretome was not modified by SP, the
peptide stimulated the biofilm formation activity. In fact, the
ability of S. epidermidis to produce biofilms on biotic surfaces,
such as skin, constitutes its primary virulence factor and allows its
dissemination in deep tissues and through bloodstream (Vuong
and Otto, 2002).
It is not clear why Staphylococci have evolved or preserved
an SP detection system. The lack of effect of the SP reversed
sequence peptide and of a closely related tachykinin, Neurokinin
A, shows the high level of specificity of the recognition system. In
B. cereus, SP was shown to bind on Ef-Tu (Mijouin et al., 2013).
Ef-Tu is a protein that is highly conserved throughout bacterial
evolution and its name is excessively restrictive in regard of its
multiple known functions. Indeed, Ef-Tu is produced in large
excess in regard to its stoechiometric association to ribosomes
and it was postulated that in stress conditions Ef-Tu translocates
to the bacterial membrane where it changes of conformation and
acquires new roles (Dallo et al., 2002, 2012). Staphylococci also
express Ef-Tu and in S. aureus Ef-Tu is found not only in the
cytoplasm but also in the cell envelope (Gatlin et al., 2006). In
the present study we observed that, as in B. cereus (Mijouin
et al., 2013), in S. aureus and S. epidermidis, SP was binding to
Ef-Tu. This suggests that Ef-Tu acts as an SP sensor in many
Gram-positive bacteria, and even potentially in other eubacteria.
Indeed, P. fluorescens, a typical Gram-negative bacterium, is also
capable of recognizing SP (Hillion et al., 2014). Although the
SP binding site was not identified in this species, Ef-Tu is also
suspected to act as a sensor in Pseudomonas (Dagorn et al.,
2013). Previous studies have shown that in different bacterial
species Ef-Tu is also acting as a membrane binding protein
for fibrinogen (Kunert et al., 2007) or plasminogen (Chung
et al., 2011). The present results extend the spectrum of Ef-
Tu as “moonlighting protein” exerting different functions in the
bacterial cytoplasm and in the membrane (Amblee and Jeffery,
2015).
The present study demonstrates that the effects of SP on the
virulence, adhesion and biofilm formation activities of S. aureus
and S. epidermidis are of potential pathophysiological relevance.
We confirm the hypothesis that SP stimulates LL37 secretion.
However, the action of SP on bacteria appears independent of
antimicrobial peptides. SP acts on S. aureus and S. epidermidis
through different mechanisms although it can be recognized at
least by the same sensor protein, Ef-Tu. This confirms that SP
acts as an inter-kingdom communication factor involved in the
regulation of skin microflora homeostasis.
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